A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients

An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and challenges involving this increasingly common procedure that still remain. Dr. Kuemmerle speaks with author Dr. Alexander Khoruts.

Development of Fecal Microbiota Transplantation

An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with ventricular assist devices. Dr. Kuemmerle speaks to co-author Dr. John Vargo of the Cleveland Clinic.

Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices

A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.

Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis

An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist demonstrates value in the era of the Affordable Care Act. Dr. Kuemmerle speaks to Dr. Lawrence Kosinski.

How Gastroenterologists Can Demonstrate Value

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.

Restarting Infliximab in IBD Patients with Prior Loss of Response

An editorial in the August issue of CGH discusses changing treatment methods for Hepatitis C Virus infection over the last several years. Dr. Kuemmerle speaks to first author Dr. Fasiha Kanwal of Baylor College of Medicine.

Evolution of Hepatitis C Virus Treatment

An article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to Dr. Kathleen Corey

Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients

A commentary in the June issue of CGH looks at the effect of proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) on the lower gastrointestinal tract. Dr. Kuemmerle speaks to author Dr. Francis KL Chan.

PPIs and NSAID–Related Lower Gastrointestinal Adverse Events

A review article in the May issue of CGH looks at the major advances in risk assessment, molecular genetics, DNA mutational analyses, and cancer prevention and management of Lynch syndrome over the last 100 years; with guest Dr. Fay Kastrinos

History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome

An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.

Clinical Gastroenterology & Hepatology

Two related articles appear in the October issue of CGH: "Methods for Diagnosis of Bile Acid Malabsorption in Clinical Practice” and “Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With IBS.”

Bile Acid Malabsorption in the Colon

A Practice Management article in the January 2012 issue of CGH outlines three major options for owners of ambulatory surgery centers (ASCs) to deal with decreased reimbursements and rising costs. Dr. Kuemmerle speaks with author Dr. Lawrence R. Kosinski

Current Options for Ambulatory Surgery Centers

A study in the December CGH finds that constipation and a low-fiber diet are not associated with diverticulosis. A related "Perspectives in Clinical Gastroenterology and Hepatology" article reconsiders conventional wisdom about diverticular disease.

Reconsidering Diverticular Disease

An article in the February issue of CGH offers a primer for gastroenterologists on the use of new anticoagulant and antiplatelet agents. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes

New Anticoagulant and Antiplatelet Agents

Eosinophilic esophagitis (EoE) has become a major cause of upper gastrointestinal morbidity in children and adults. A study in the April issue of CGH estimates the prevalence of EoE in the United States. Dr. Kuemmerle speaks to author Dr. Evan S. Dellon

Prevalence of Eosinophilic Esophagitis in the U.S.

An “Advances in Translational Science” article in the March issue of CGH looks at the future of DNA testing and molecular screening for colon cancer. Dr. Kuemmerle speaks with author Dr. John M. Carethers of the University of Michigan Dept of Medicine

DNA Testing and Molecular Screening for Colon Cancer

A phase 2 study in the January 2014 issue of CGH investigated the efficacy of allogeneic mesenchymal stromal cells in patients with luminal Crohn's disease. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes

A Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

Colonic Crohn

A study in the March issue of CGH looks at whether primary sclerosing cholangitis is also a risk factor for colorectal dysplasia or cancer in patients with Crohn's disease of the colon. Dr. Kuemmerle speaks with senior author Dr. Roger Chapman

Colorectal Neoplasia Risk in Patients with Colonic Crohn's Disease and Concomitant Primary Sclerosing Cholangitis

A review in the November issue of CGH provides a practical guide to evaluation and management of pregnant patients with abnormal liver chemistries or function.  Dr. Kuemmerle speaks to Dr. Mary E. Rinella

Interpretation and Management of Hepatic Abnormalities in Pregnancy

An article in the September issue of CGH summarizes the pathophysiology of hemostasis in liver disease, describes pros and cons of lab tests for those patients, and outlines the optimal management of hemostasis for various clinical scenarios.

Coagulation in Liver Disease: A Guide for the Clinician

An article in the August CGH discusses the dangers and advantages physicians should consider when utilizing the internet and social media in their medical practices or private communications.  Dr. Kuemmerle speaks to Dr. Andrew D. Feld.

Internet Liability for Gastroenterologists

A study in the July issue of CGH compares the colonic microbiome and volatile organic compound metabolome of obese nonalcoholic fatty liver disease patients with that of healthy-weight individuals.  Dr. Kuemmerle speaks to author Dr. Kevin P. Rioux.

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Nonalcoholic Fatty Liver Patients

A study in the June issue of CGH looks at whether a test-based or empiric dose-escalation strategy is more cost-effective for treating Crohn's disease patients who have stopped responding to Infliximab. Dr. Kuemmerle speaks to Dr. Fernando S. Velayos.

Cost-Effective Treatment for Crohn's Disease Patients Who Lose Responsiveness to Infliximab

Two articles in the May issue of CGH look examine side effects and complications of long-term proton pump inhibitor use, and fundoplication for GERD treatment. Dr. Kuemmerle discusses the pros and cons of each approach with the authors of these articles.

Side Effects and Complications of Long-Term PPI Use or Fundoplication for GERD Treatment

An editorial in the April issue of CGH takes a new look at the risks and benefits of thiopurines in treating Crohn's disease. Dr. Kuemmerle speaks to Dr. Stephen B. Hanauer of the University of Chicago Medical Center

Reassessing the Risks and Benefits of Thiopurines in Crohn's Disease

The best podcast episodes on Startups. For anyone working in a startup, or anyone interested in the incredible stories behind how people built companies like Instagram, and Facebook. Offering both practical advice and insights, as well as the stories for how many of the biggest startups got to where they are today. Add episodes you're interested into your queue below!

OwlTail

Best Startups Podcasts

The best podcast episodes of anyone with an interesting story. With famous guests like Obama, LeBron James, Drake, Oprah Winfrey, Richard Branson, Michelle Obama, Serena Williams, to anyone who has a unique and interesting story to tell. Add episodes you're interested into your queue below!